Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)

Clinical trial NCT07513324 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07513324
Sponsor: Dana-Farber Cancer Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HPV-positive Oropharyngeal Squamous Cell Carcinoma Oropharyngeal Squamous Cell Carcinoma

Start date: 2026-07-01
Primary completion: 2028-01-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.